Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MON1 Homolog B (MON1B) (N-Term) Peptid

MON1B Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN980181
  • Target Alle MON1B Produkte
    MON1B (MON1 Homolog B (MON1B))
    Protein Region
    N-Term
    Spezies
    Human
    Quelle
    • 1
    Synthetic
    Applikation
    Blocking Peptide (BP), Western Blotting (WB)
    Sequenz
    TQFPSEEARE GGGVHAVPPD PEDEGLEETG SKDKDQPPSP SPPPQSEALS
    Produktmerkmale
    This is a synthetic peptide designed for use in combination with anti-MON1B Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Aufreinigung
    Purified
  • Applikationshinweise
    Each Investigator should determine their own optimal working dilution for specific applications.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Konzentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Handhabung
    Avoid repeated freeze-thaw cycles.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    MON1B (MON1 Homolog B (MON1B))
    Synonyme
    5031407H10 Peptide, 5033413H12Rik Peptide, HSRG1 Peptide, SAND2 Peptide, SRG1 Peptide, MON1 homolog B, secretory traffciking associated Peptide, MON1 homolog B, secretory trafficking associated Peptide, Mon1b Peptide, MON1B Peptide
    Hintergrund
    The function of this protein remains unknown.

    Alias Symbols: HSRG1, SAND2, SRG1

    Protein Interaction Partner: FYCO1

    Protein Size: 547
    Molekulargewicht
    60 kDa
    Gen-ID
    22879
    NCBI Accession
    NM_003776, NP_003767
    UniProt
    Q9NQ50
Sie sind hier:
Kundenservice